acquired
Stage
About
Immunomedics, Inc. is a biopharmaceutical company focused on the development and commercialization of antibody-drug conjugate therapies for the treatment of cancer.
Explore Immunomedics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.